Ustekinumab for the treatment of chronic plaque psoriasis and psoriatic arthritis

Published on 03 May 2017
Last Updated on 03 May 2017

Guidance Recommendation

The Ministry of Health’s Drug Advisory Committee has not recommended ustekinumab to be listed on the Medication Assistance Fund (MAF) for the treatment of chronic plaque psoriasis and psoriatic arthritis.

Ustekinumab in Psoriasis (for 3 May 2017) [PDF, 543 KB]